SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / General: GRN Carrier Resilience: Why Some Mutation Carriers Remain As

general 842 words KG: GRN 2026-03-28

state:published

Contents

GRN Carrier Resilience: Why Some Mutation Carriers Remain Asymptomatic

Knowledge Graph

Related Hypotheses (30)

Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.42 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 SASP-Driven Aquaporin-4 Dysregulation
Score: 0.59

Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54 Glymphatic System-Enhanced Antibody Clearance Reversal
Score: 0.54 Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53 Phase-Separated Organelle Targeting
Score: 0.52 Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52 GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52 Aquaporin-4 Polarization Rescue
Score: 0.51 Astroglial Gap Junction Coordination via Connexin-43 Phospho
Score: 0.50 Stress Granule Phase Separation Modulators
Score: 0.49 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 Complement C1q Mimetic Decoy Therapy
Score: 0.48 RNA Granule Nucleation Site Modulation
Score: 0.48 APOE-TREM2 Interaction Modulation
Score: 0.48 APOE Isoform Expression Across Glial Subtypes
Score: 0.48 Cryptic Exon Silencing Restoration
Score: 0.46 Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46 Cross-Seeding Prevention Strategy
Score: 0.45 LRP1-Dependent Tau Uptake Disruption
Score: 0.44 Complement C1q Subtype Switching
Score: 0.44 TREM2-Mediated Selective Aggregate Clearance Pathway
Score: 0.43 Glycine-Rich Domain Competitive Inhibition
Score: 0.43 Complement C1QA Spatial Gradient in Cortical Layers
Score: 0.43 CX43 hemichannel engineering enables size-selective mitochon
Score: 0.41 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41

Related Analyses (12)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived How do pathological stress granules in neurodegeneration esc
neurodegeneration · failed RNA binding protein dysregulation across ALS FTD AD
neurodegeneration · failed TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · completed

RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · completed 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas
neurodegeneration · completed

Related Experiments (11)

Presymptomatic GRN Carrier Intervention Timing — Biomarker-G
clinical · proposed · Score: 0.40 CRISPR Gene Correction Approaches for CBS/PSP
clinical · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 Frontal and Temporal Lobe Selective Vulnerability in FTD — M
validation · proposed · Score: 0.40 FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40

Macroautophagy Dysfunction in PD - Experiment Design
clinical · proposed · Score: 0.40 Non-Motor Symptom Progression in Parkinson's Disease — Mecha
clinical · proposed · Score: 0.40 Progranulin Replacement Therapy for FTD — Vector Development
clinical · proposed · Score: 0.40 Mechanism: Progranulin Loss and TDP-43 Pathology in FTD
validation · proposed · Score: 0.40 TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.40 TMEM106B Haplotype as Genetic Modifier in FTD — Mechanism an
validation · proposed · Score: 0.40

See Also (8)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: causes Packard Center for ALS Research
institution · KG edge: activates adam17
gene · KG edge: associated_with ADAM10 — A Disintegrin And Metalloproteinase Domain 10
gene · KG edge: associated_with ACE Gene
gene · KG edge: associated_with

ABI3 Gene
gene · KG edge: associated_with ABCA1 - ATP-Binding Cassette Transporter A1
gene · KG edge: associated_with ABCA7 (Redirect)
redirect · KG edge: associated_with

Knowledge Graph (12 edges)

GRN therapeutic_target FUS

GRN therapeutic_target SOD1

GRN therapeutic_target C9ORF72

GRN encodes progranulin

GRN associated_with frontotemporal lobar degeneration

GRN inhibits aberrant microglia activation

GRN activates CTSB

GRN associated_with GAIN

GRN associated_with MAPT

GRN activates SPP1

SciDEX — scidex.ai — Dashboard | Atlas